NeuroBo Pharmaceuticals, Inc

$6.30
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.67 (+11.59%) Today
-$0.15 (-2.33%) As of 10:20 AM UTC after-hours

Why Robinhood?

You can buy or sell NRBO and other stocks, options, and ETFs commission-free!

About NRBO

NeuroBo Pharmaceuticals, Inc. Common Stock, also called NeuroBo Pharmaceuticals, Inc, is a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders. The company was founded on October 30, 2014 and is headquartered in Boston, MA. The listed name for NRBO is NeuroBo Pharmaceuticals, Inc. Common Stock.

CEO
Jeong Gu Kang
Employees
12
Headquarters
Boston, Massachusetts
Founded
2014
Market Cap
133.36M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
306.86K
High Today
$6.48
Low Today
$5.20
Open Price
$5.69
Volume
483.14K
52 Week High
$30.00
52 Week Low
$4.82

Collections

NRBO Earnings

-$3.37
-$2.25
-$1.12
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Mar 29, After Hours

You May Also Like

CDE
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure